Ropivacaine Reactions 1680, p303 - 2 Dec 2017 Acute brainstem dysfunction secondary to total spinal and brainstem anesthesia: case report A 51-year-old woman developed acute brainstem dysfunction secondary to total spinal and brain stem anaesthesia, after receiving paravertebral administration of 0.2% ropivacaine 120mg for six hours. The woman had severe chronic obstructive pulmonary disease, and underwent lung transplantation for the same. After the surgery, she received ropivacaine infusion through a T7-T8 paravetebral catheter as postoperative analgesia. She developed quadriparesis after a while [duration of treatment to reaction onset not clearly stated]. Around 5.5 hours after the administration, her pupils in both eyes became fixed and dilated. Her tone became flaccid. Her deep tendon reflexes were missing, while her toes were unresponsive to any stimulation. An absence of horizontal eye movements was observed in an oculocephalic maneuver. The woman’s treatment with ropivacaine was stopped. Her systolic B.P was above 90mm Hg while on norepinephrine. She became conscious after elevating the head of bed. She regained strength in her arms, and an hour later she was able to move her legs. Her pupils became normal with full extraocular movements, but her bilateral end-gaze nystagmus was present for several hours. An MRI scan showed a collection of fluid in the epidural region. She was extubated on the next day. She complained of headache and nausea, which improved after lying flat and administration of caffeine and analgesics. She went home after ten days without any neurologic sequelae. Author comment: "We report a case of total spinal and brain-stem anaesthesia, defined as anaesthetic block of the cervical cord and brainstem or cranial nerves, following paravertebral ropivacaine anaesthesia." Foster LA, et al. Total spinal and brainstem anesthesia as complication of paravertebral ropivacaine administration. Neurology: Clinical Practice 7: 430-432, No. 5, Oct 2017. Available from: URL: CPJ.0000000000000355 - USA 803284869 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial